| 43 |
morphological change |
|
hippocampal formation
(UBERON:0002421)
|
None
|
| 31 |
decreased |
weight loss
(MP:0001263)
|
|
None
|
| 523 |
decreased |
survival
(MESH:D013534)
|
|
None
|
| 508 |
decreased |
|
estrogen
(CHEBI:50114)
|
None
|
| 104 |
morphological change |
developmental process
(GO:0032502)
|
cardiovascular system
(UBERON:0004535)
|
None
|
| 418 |
decreased |
catalytic activity
(GO:0003824)
|
3-oxo-5-alpha-steroid 4-dehydrogenase 2 (rat)
(PR:P31214)
|
None
|
| 474 |
decreased |
epithelial cell apoptotic process
(GO:1904019)
|
|
None
|
| 177 |
functional change |
mitochondrion disassembly
(GO:0061726)
|
mitochondrion
(GO:0005739)
|
None
|
| 87 |
occurrence |
oxidative stress
(MP:0003674)
|
|
None
|
| 103 |
disrupted |
protein dimerization activity
(GO:0046983)
|
aryl hydrocarbon receptor nuclear translocator
(PR:000004303)
|
None
|
| 61 |
decreased |
glutamate secretion, neurotransmission
(GO:0061535)
|
glutamate(1-)
(CHEBI:14321)
|
None
|
| 44 |
abnormal |
chemical synaptic transmission
(GO:0007268)
|
|
None
|
| 480 |
increased |
secretion
(GO:0046903)
|
mucin-5AC
(PR:000031343)
|
None
|
| 514 |
increased |
Immunosuppression
(MESH:D007165)
|
|
None
|
| 556 |
morphological change |
|
Metaplasia
(MESH:D008679)
|
None
|
| 365 |
increased |
epithelial cell proliferation
(GO:0050673)
|
nephron tubule epithelial cell
(CL:1000494)
|
None
|
| 429 |
decreased |
|
cholesterol
(CHEBI:16113)
|
None
|
| 86 |
decreased |
|
glutathione
(CHEBI:16856)
|
None
|
| 102 |
disrupted |
protein dimerization activity
(GO:0046983)
|
aryl hydrocarbon receptor
(PR:000003858)
|
None
|
| 560 |
delayed |
estrus
(GO:0060209)
|
|
None
|
| 36 |
disrupted |
ovulation cycle
(GO:0042698)
|
|
None
|
| 187 |
increased |
|
fatty liver
(MESH:D005234)
|
None
|
| 74 |
functional change |
DNA repair
(GO:0006281)
|
deoxyribonucleic acid
(CHEBI:16991)
|
None
|
| 509 |
decreased |
neurotransmitter secretion
(GO:0007269)
|
metastasis-suppressor KiSS-1 (rat)
(PR:Q7TSB7)
|
None
|
| 482 |
occurrence |
mucus secretion
(GO:0070254)
|
|
None
|